Erasca (ERAS) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ERAS Stock Forecast

Erasca stock forecast is as follows: an average price target of $6.50 (represents a 146.21% upside from ERAS’s last price of $2.64) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

ERAS Price Target

The average price target for Erasca (ERAS) is $6.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $7.00 to $6.00. This represents a potential 146.21% upside from ERAS's last price of $2.64.

ERAS Analyst Ratings

Buy

According to 4 Wall Street analysts, Erasca's rating consensus is 'Buy'. The analyst rating breakdown for ERAS stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Erasca Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 18, 2024	Maury Raycroft	Jefferies	$6.00	$2.40	150.00%	127.27%
Apr 01, 2024	Chris Shibutani	Goldman Sachs	$7.00	$2.21	216.74%	165.15%

Row per page

Go to

The latest Erasca stock forecast, released on Nov 18, 2024 by Maury Raycroft from Jefferies, set a price target of $6.00, which represents a 150.00% increase from the stock price at the time of the forecast ($2.40), and a 127.27% increase from ERAS last price ($2.64).

Erasca Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	2
Avg Price Target	$6.00	$6.00	$6.50
Last Closing Price	$2.64	$2.64	$2.64
Upside/Downside	127.27%	127.27%	146.21%

In the current month, the average price target of Erasca stock is $6.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 127.27% increase as opposed to Erasca's last price of $2.64. This month's average price target is down 0.00% compared to last quarter, and down -7.69% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 18, 2024	Jefferies	-	Buy	Initialise
Aug 13, 2024	H.C. Wainwright	Buy	Buy	Hold
May 20, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 01, 2024	Goldman Sachs	Buy	Buy	Hold
Feb 03, 2023	Morgan Stanley	-	Overweight	Upgrade

Row per page

Go to

Erasca's last stock rating was published by Jefferies on Nov 18, 2024. The company Initialise its ERAS rating from "null" to "Buy".

Erasca Financial Forecast

Erasca Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Erasca's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ERAS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Erasca EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict ERAS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Erasca's previous annual EBITDA (undefined) of $NaN.

Erasca Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-84.53M	$-81.49M	$-75.29M	$-72.23M	$-78.29M	$-75.47M	$-69.73M	$-66.89M	$-48.01M	$-43.77M	$-42.36M	$-39.53M	$-40.30M	$-47.18M	$-39.87M
High Forecast	$-84.53M	$-81.49M	$-75.29M	$-72.23M	$-78.29M	$-75.47M	$-69.73M	$-66.89M	$-48.01M	$-43.77M	$-42.36M	$-31.63M	$-34.54M	$-47.18M	$-39.87M
Low Forecast	$-84.53M	$-81.49M	$-75.29M	$-72.23M	$-78.29M	$-75.47M	$-69.73M	$-66.89M	$-48.01M	$-43.77M	$-42.36M	$-44.81M	$-48.94M	$-47.18M	$-39.87M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Erasca's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ERAS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Erasca SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Erasca's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ERAS last annual SG&A of $NaN (undefined).

Erasca EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-0.30	$-0.29	$-0.27	$-0.26	$-0.28	$-0.27	$-0.25	$-0.24	$-0.17	$-0.15	$-0.15	$-0.14	$-0.14	$-0.17	$-0.18
High Forecast	$-0.30	$-0.29	$-0.27	$-0.26	$-0.28	$-0.27	$-0.25	$-0.24	$-0.17	$-0.15	$-0.15	$-0.11	$-0.12	$-0.17	$-0.18
Low Forecast	$-0.30	$-0.29	$-0.27	$-0.26	$-0.28	$-0.27	$-0.25	$-0.24	$-0.17	$-0.15	$-0.15	$-0.16	$-0.17	$-0.17	$-0.18
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Erasca's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ERAS previous annual EPS of $NaN (undefined).

Erasca Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
IPSC	Century Therapeutics	$1.26	$15.00	1090.48%	Buy
NGM	NGM Biopharmaceuticals	$1.54	$16.50	971.43%	Buy
ZNTL	Zentalis Pharmaceuticals	$3.13	$21.86	598.40%	Buy
BDTX	Black Diamond Therapeutics	$2.43	$14.75	507.00%	Buy
LIFE	aTyr Pharma	$1.90	$11.00	478.95%	Buy
RLAY	Relay Therapeutics	$4.66	$19.40	316.31%	Buy
OLMA	Olema Pharmaceuticals	$8.28	$28.50	244.20%	Buy
CCCC	C4 Therapeutics	$4.05	$13.50	233.33%	Buy
SANA	Sana Bio	$2.53	$8.00	216.21%	Buy
ARVN	Arvinas	$22.69	$71.00	212.91%	Buy
PLRX	Pliant Therapeutics	$12.73	$39.71	211.94%	Buy
STOK	Stoke Therapeutics	$11.31	$30.60	170.56%	Buy
CGEM	Cullinan Oncology	$12.58	$31.50	150.40%	Buy
ERAS	Erasca	$2.64	$6.50	146.21%	Buy
MLYS	Mineralys Therapeutics	$12.60	$30.00	138.10%	Buy
KROS	Keros Therapeutics	$54.14	$102.60	89.51%	Buy
DSGN	Design Therapeutics	$5.48	$9.67	76.46%	Buy
EWTX	Edgewise Therapeutics	$31.95	$45.00	40.85%	Buy
GRCL	Gracell Bio	$10.25	$6.00	-41.46%	Buy

ERAS Forecast FAQ

Is Erasca a good buy?

Yes, according to 4 Wall Street analysts, Erasca (ERAS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of ERAS's total ratings.

What is ERAS's price target?

Erasca (ERAS) average price target is $6.5 with a range of $6 to $7, implying a 146.21% from its last price of $2.64. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Erasca stock go up soon?

According to Wall Street analysts' prediction for ERAS stock, the company can go up by 146.21% (from the last price of $2.64 to the average price target of $6.5), up by 165.15% based on the highest stock price target, and up by 127.27% based on the lowest stock price target.

Can Erasca stock reach $4?

ERAS's average twelve months analyst stock price target of $6.5 supports the claim that Erasca can reach $4 in the near future.

What is Erasca's current price target trend?

1 Wall Street analyst forecast a $6 price target for Erasca (ERAS) this month, up 127.27% from its last price of $2.64. Compared to the last 3 and 12 months, the average price target increased by 127.27% and increased by 146.21%, respectively.

What are Erasca's analysts' financial forecasts?

Erasca's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-290M (high $-290M, low $-290M), average SG&A $0 (high $0, low $0), and average EPS is $-1.028 (high $-1.028, low $-1.028). ERAS's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-314M (high $-314M, low $-314M), average SG&A $0 (high $0, low $0), and average EPS is $-1.11 (high $-1.11, low $-1.11).